Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0342 Transporter Info | ||||
Gene Name | SLC39A14 | ||||
Transporter Name | Zinc transporter ZIP14 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ATF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in hepatic endoplasmic reticulum stres condition | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-4 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatic endoplasmic reticulum stres [ICD11: N.A.] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6J-129S5 hybrid mice | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-4 (ATF4) has been reported to activate the transcription of SLC39A14 gene in hepatic endoplasmic reticulum stres condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
ATF6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in hepatic endoplasmic reticulum stres condition | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-6 alpha | Transcription Factor Info | ||||
Studied Phenotype |
Hepatic endoplasmic reticulum stres [ICD11: N.A.] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6J-129S5 hybrid mice | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-6 alpha (ATF6) has been reported to activate the transcription of SLC39A14 gene in hepatic endoplasmic reticulum stres condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in liver inflammation condition | [5] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
Liver inflammation [ICD11: DB97] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to activate the transcription of SLC39A14 gene in liver inflammation condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
HIF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in inflammation condition | [7] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Inflammation [ICD11: 1H0Z] | |||||
Tissue |
Knee | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human knee fibroblast-like synoviocyte isolates | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC39A14 gene in inflammation condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in melanoma condition | [8] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC39A14 gene in melanoma condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Tissue |
Coronary artery | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 21 (TCF21) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Cervix; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
TFAP2C |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in breast cancer condition | [9] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC39A14 gene in breast cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A14 gene in health condition | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC39A14 gene in health condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
PGR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Progesterone receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Progesterone receptor (PGR) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
GATA4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in gastric cancer condition | [11] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC39A14 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Embryo; Skin; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in gastric cancer condition | [11] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of SLC39A14 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A14 gene in erythroleukemia condition | [12] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC39A14 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in gastric cancer condition | [11] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC39A14 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
WT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in podocyte condition | [13] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC39A14 gene in podocyte condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ZNF384 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Zinc finger protein 384 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 384 (ZNF384) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CUX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in multiple human cancer types condition | [14] | ||||
TF Protein Name |
Homeobox protein cut-like 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein cut-like 1 (CUX1) has been reported to activate the transcription of SLC39A14 gene in multiple human cancer types condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A14 gene in HESC condition | [15] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to activate the transcription of SLC39A14 gene in HESC condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
E2F8 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F8 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F8 (E2F8) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
FOXA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A14 gene | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC39A14 gene in . condition, which leads to a affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
ETS2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Protein C-ets-2 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-2 (ETS2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [1] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene in colorectal cancers condition | [16] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to bind to the transcription of SLC39A14 gene in colorectal cancers condition, which leads to a affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MEF2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [6] | ||||
TF Protein Name |
Myocyte-specific enhancer factor 2A | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myocyte-specific enhancer factor 2A (MEF2A) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A14 gene in stress response condition | [17] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to bind to the transcription of SLC39A14 gene in stress response condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Transcriptional Phenomenon2 |
Repression of SLC39A14 gene in hepatoblastoma condition | [18] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC39A14 gene in hepatoblastoma condition, which leads to a decreased expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A14 gene in epithelial to mesenchymal transition condition | [19] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC39A14 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 14. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [4] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A14 gene | [3] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC39A14 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 14. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.